Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2025-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 98% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Bioneer Corporation, covering the fiscal year 2024. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It is not an announcement of a report (RPA) because it contains the full financial data and audit findings. It is distinct from a 10-K as it focuses specifically on the audit and financial statements rather than the broader business narrative found in a full annual report. FY 2024
2025-03-21 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Bioneer Corporation. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and financial statements. This document is a formal proxy statement and meeting notice sent to shareholders to solicit votes for the upcoming AGM, which fits the definition of a Proxy Solicitation & Information Statement.
2025-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by Bioneer Corporation. This is a standard regulatory filing in South Korea (DART system) used to report insider trading or changes in share ownership by directors and major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2025-03-04 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Bioneer Corporation. It contains the agenda for the upcoming Annual General Meeting (AGM), including voting items such as financial statement approval, director appointments, and remuneration limits. It also includes management reports and business overviews typically found in proxy materials. This document is a formal solicitation of shareholder votes and information for the meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including agenda items (financial statements, director appointments), voting procedures (electronic voting, proxy solicitation), and candidate information. This is a standard proxy solicitation document sent to shareholders to request their votes for the meeting.
2025-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Bioneer regarding a significant change in revenue or profit/loss structure (30% or more). It provides a comparative table of financial results (revenue, operating profit, net income) between the current and previous fiscal years, explains the reasons for the variance (inventory valuation, exchange rates), and notes that it is based on K-IFRS and subject to audit. This is a standard financial disclosure filing in the Korean market, which falls under the 'Earnings Release' (ER) category as it provides the initial announcement of financial performance highlights. FY 2024
2025-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.